DE2442655C3 - Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation - Google Patents

Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation

Info

Publication number
DE2442655C3
DE2442655C3 DE2442655A DE2442655A DE2442655C3 DE 2442655 C3 DE2442655 C3 DE 2442655C3 DE 2442655 A DE2442655 A DE 2442655A DE 2442655 A DE2442655 A DE 2442655A DE 2442655 C3 DE2442655 C3 DE 2442655C3
Authority
DE
Germany
Prior art keywords
immunoglobulins
amidated
immunoglobulin
intravenous administration
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2442655A
Other languages
German (de)
English (en)
Other versions
DE2442655B2 (de
DE2442655A1 (de
Inventor
Rudolf 3550 Marburg Schmidtberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2442655A priority Critical patent/DE2442655C3/de
Priority to NL7510289A priority patent/NL7510289A/xx
Priority to IT26918/75A priority patent/IT1048485B/it
Priority to IL48049A priority patent/IL48049A/xx
Priority to NZ178580A priority patent/NZ178580A/xx
Priority to CH1147275A priority patent/CH615194A5/de
Priority to AU84536/75A priority patent/AU499871B2/en
Priority to LU73328A priority patent/LU73328A1/xx
Priority to GB36451/75A priority patent/GB1517026A/en
Priority to ZA00755687A priority patent/ZA755687B/xx
Priority to DK399175A priority patent/DK399175A/da
Priority to SE7509898A priority patent/SE403704B/xx
Priority to CA235,134A priority patent/CA1056819A/en
Priority to IE1944/75A priority patent/IE41671B1/en
Priority to FR7527354A priority patent/FR2283695A1/fr
Priority to AT689475A priority patent/AT342763B/de
Priority to BR7505721*A priority patent/BR7505721A/pt
Priority to EG521/75A priority patent/EG11813A/xx
Priority to JP50107581A priority patent/JPS5161623A/ja
Priority to BE159842A priority patent/BE833186A/xx
Priority to AR260263A priority patent/AR212909A1/es
Publication of DE2442655A1 publication Critical patent/DE2442655A1/de
Priority to US05/770,181 priority patent/US4118379A/en
Publication of DE2442655B2 publication Critical patent/DE2442655B2/de
Application granted granted Critical
Publication of DE2442655C3 publication Critical patent/DE2442655C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE2442655A 1974-09-06 1974-09-06 Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation Expired DE2442655C3 (de)

Priority Applications (22)

Application Number Priority Date Filing Date Title
DE2442655A DE2442655C3 (de) 1974-09-06 1974-09-06 Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation
NL7510289A NL7510289A (nl) 1974-09-06 1975-09-01 Geamideerde immuunglobulinen en werkwijze ter bereiding daarvan.
IL48049A IL48049A (en) 1974-09-06 1975-09-04 Amidated immuno-globulines and process for preparing them
NZ178580A NZ178580A (en) 1974-09-06 1975-09-04 Amidated immune globulins and pharmaceutical compositions
CH1147275A CH615194A5 (en) 1974-09-06 1975-09-04 Process for the preparation of amidated immunoglobulins
AU84536/75A AU499871B2 (en) 1974-09-06 1975-09-04 Amidated immune globulines
LU73328A LU73328A1 (US06589383-20030708-C00041.png) 1974-09-06 1975-09-04
GB36451/75A GB1517026A (en) 1974-09-06 1975-09-04 Immune globulins and process for their preparation
IT26918/75A IT1048485B (it) 1974-09-06 1975-09-04 Immunoglobuline amioate e processo per la loro preparazione
IE1944/75A IE41671B1 (en) 1974-09-06 1975-09-05 Modified imune globulins and process for their preparation
SE7509898A SE403704B (sv) 1974-09-06 1975-09-05 Forfarande for framstellning av amiderade immunglobuliner
CA235,134A CA1056819A (en) 1974-09-06 1975-09-05 Amidated immune globulines and process for preparing them
ZA00755687A ZA755687B (en) 1974-09-06 1975-09-05 Amidated immune globulines and process for preparing them
FR7527354A FR2283695A1 (fr) 1974-09-06 1975-09-05 Immunoglobulines modifiees, leur procede de preparation et leurs applications
AT689475A AT342763B (de) 1974-09-06 1975-09-05 Verfahren zur herstellung von neuen, amidierten immunglobulinen
BR7505721*A BR7505721A (pt) 1974-09-06 1975-09-05 Imunoglobulinas amidadas e processo para sua preparacao
DK399175A DK399175A (da) 1974-09-06 1975-09-05 Amiderede immunglobuliner og fremgangsmade til deres fremstilling
EG521/75A EG11813A (en) 1974-09-06 1975-09-06 Process for preparing of imidated immune globulines
JP50107581A JPS5161623A (US06589383-20030708-C00041.png) 1974-09-06 1975-09-06
BE159842A BE833186A (fr) 1974-09-06 1975-09-08 Immunoglobulines modifiees, leur procede de preparation et leurs applications
AR260263A AR212909A1 (es) 1974-09-06 1975-09-14 Procedimiento para la preparacion de inmunoglobulinas amidificadas
US05/770,181 US4118379A (en) 1974-09-06 1977-02-18 Amidated immune globulins and process for preparing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2442655A DE2442655C3 (de) 1974-09-06 1974-09-06 Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation

Publications (3)

Publication Number Publication Date
DE2442655A1 DE2442655A1 (de) 1976-03-18
DE2442655B2 DE2442655B2 (de) 1979-02-01
DE2442655C3 true DE2442655C3 (de) 1979-09-20

Family

ID=5925019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2442655A Expired DE2442655C3 (de) 1974-09-06 1974-09-06 Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation

Country Status (21)

Country Link
JP (1) JPS5161623A (US06589383-20030708-C00041.png)
AR (1) AR212909A1 (US06589383-20030708-C00041.png)
AT (1) AT342763B (US06589383-20030708-C00041.png)
AU (1) AU499871B2 (US06589383-20030708-C00041.png)
BE (1) BE833186A (US06589383-20030708-C00041.png)
BR (1) BR7505721A (US06589383-20030708-C00041.png)
CA (1) CA1056819A (US06589383-20030708-C00041.png)
CH (1) CH615194A5 (US06589383-20030708-C00041.png)
DE (1) DE2442655C3 (US06589383-20030708-C00041.png)
DK (1) DK399175A (US06589383-20030708-C00041.png)
EG (1) EG11813A (US06589383-20030708-C00041.png)
FR (1) FR2283695A1 (US06589383-20030708-C00041.png)
GB (1) GB1517026A (US06589383-20030708-C00041.png)
IE (1) IE41671B1 (US06589383-20030708-C00041.png)
IL (1) IL48049A (US06589383-20030708-C00041.png)
IT (1) IT1048485B (US06589383-20030708-C00041.png)
LU (1) LU73328A1 (US06589383-20030708-C00041.png)
NL (1) NL7510289A (US06589383-20030708-C00041.png)
NZ (1) NZ178580A (US06589383-20030708-C00041.png)
SE (1) SE403704B (US06589383-20030708-C00041.png)
ZA (1) ZA755687B (US06589383-20030708-C00041.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004697A (en) * 1987-08-17 1991-04-02 Univ. Of Ca Cationized antibodies for delivery through the blood-brain barrier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3704282A (en) * 1971-04-09 1972-11-28 Sidney Spector Catecholamine antigens and antibodies specific therefor

Also Published As

Publication number Publication date
CH615194A5 (en) 1980-01-15
AU8453675A (en) 1977-03-10
DE2442655B2 (de) 1979-02-01
CA1056819A (en) 1979-06-19
SE403704B (sv) 1978-09-04
AR212909A1 (es) 1978-11-15
DK399175A (da) 1976-03-07
GB1517026A (en) 1978-07-05
DE2442655A1 (de) 1976-03-18
EG11813A (en) 1978-09-30
IL48049A0 (en) 1975-11-25
SE7509898L (sv) 1976-03-08
IE41671B1 (en) 1980-02-27
NL7510289A (nl) 1976-03-09
ATA689475A (de) 1977-08-15
IT1048485B (it) 1980-11-20
ZA755687B (en) 1976-08-25
FR2283695A1 (fr) 1976-04-02
BE833186A (fr) 1976-03-08
BR7505721A (pt) 1976-08-03
LU73328A1 (US06589383-20030708-C00041.png) 1977-05-11
JPS5161623A (US06589383-20030708-C00041.png) 1976-05-28
NZ178580A (en) 1978-03-06
FR2283695B1 (US06589383-20030708-C00041.png) 1978-09-22
IE41671L (en) 1976-03-06
IL48049A (en) 1978-08-31
AU499871B2 (en) 1979-05-03
AT342763B (de) 1978-04-25

Similar Documents

Publication Publication Date Title
DE69629127T2 (de) TRENNMEDIUM FÜR IgG UND PROTEIN A VARIANTE
DE69821741T2 (de) Immunoglobulin enthaltende zusammensetzung
DE2633246A1 (de) Neue poroese materialien kationischen charakters sowie deren herstellung und deren anwendung zur reversiblen fixierung von biologischen makromolekuelen
CH619614A5 (US06589383-20030708-C00041.png)
CH655010A5 (de) Pharmazeutischer wirkstoff mit antitumoraktivitaet.
EP0413188B1 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate
DE2322552C2 (de) Verfahren zum Abtrennen von Protein A aus Staphylococcus aureus aus einer Flüssigkeit
DD216384A5 (de) Verfahren zur herstellung von lyophilisierten adsorbierten kombinierten vakzinen
DE69826851T2 (de) Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen
DE2406167A1 (de) Verfahren zur herstellung von stabilen suspensionen von lebensfaehigen viren
DE3314999A1 (de) Verwendung des diterpen-derivates forskolin zur immunstimulation
DE2541931A1 (de) Immunologische verbindungen
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
EP0363835A1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
DE2442655C3 (de) Amidierte Immunglobuline und ihre Verwendung zur intravenösen Applikation
DE2448530C3 (de) Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
DE2413512A1 (de) Verfahren zur verlaengerung der wirkung pharmazeutischer substanzen
DE69815769T2 (de) Antitumormittel enthaltend einen Komplex einer Oxidoreduktase und eines Polymers und ein Substrat des Enzyms
EP0001443B1 (de) Mittel zur Konzeptionsverhütung und Schwangerschaftsunterbrechung bei Primaten und Verfahren zu ihrer Herstellung
CH639394A5 (de) Verfahren zur herstellung von immunglobulinpraeparationen mit verminderter komplementaktivitaet.
EP0022426B1 (de) Nasalpräparate und Verfahren zu deren Herstellung
DE2637022C3 (de) Amidierte Immunglobuline und deren Verwendung
DE2646223C2 (US06589383-20030708-C00041.png)
EP0395851A1 (de) Glykoproteine aus Avena sativa, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutischer Wirkstoff

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee